Healthcare

Orthocell Limited (ASX:OCC)

Industry Group : Pharmaceuticals, Biotechnology & Life Sciences | Industry Group Name : Biotechnology

Market Price : AUD 0.5150.01 (1.98%)

(as on 2021-11-30 20:56:56 AEDT)

Market Cap : AUD 100.086 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.505 0.5 0.515 0.500L 0.515 H 0.405L 0.655 H
Last Trade 0.515
Change% 1.9802
52 W H/L 0.655/0.405
EBITDA -11.669 M
NPAT After Abnormal Items -9.037 M
Equity 16.874 M
ROE% -53.55%
Total Liabilities 2.456 M
Total Revenue 1.057 M
Cash and Cash Equivalents 16.329 M

Stock Information

Share price 0.515
Market Cap 100.086 M
Price/Gross Cash Flow -14.59
Dividend Yield Excluding Special 0.00%
Ending Shares 190.584 M
52-Week Range 0.655-0.405
P/E ratio 0.000
Sector P/E --
EPS -4.70
EV/EBITDA --
Net Profit Margin (%) -887.76%
Gross Cash Flows Per Share -0.04
Net Gearing -93.08%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.08
Sales Per Share 0.01
Book Value Per Share 0.09

Announcements

Heading Date/Time
Ortho-ATI Shoulder Tendon Study Database Lock  15/11/2021 9:54AM
Notice under Section 708(A) of the Corporations Act  09/11/2021 8:01PM
Application for quotation of securities - OCC  09/11/2021 7:56PM
Appendix 4C - Quarterly  29/10/2021 10:01AM
Presentation - Canaccord Genuity South-West Connect Showcase  28/10/2021 9:52AM
Results of Meeting  27/10/2021 3:54PM
Notification regarding unquoted securities - OCC  26/10/2021 8:14PM
Notification regarding unquoted securities - OCC  26/10/2021 8:08PM
Notification regarding unquoted securities - OCC  26/10/2021 7:50PM
Notification regarding unquoted securities - OCC  26/10/2021 7:41PM
Notification regarding unquoted securities - OCC  26/10/2021 7:37PM
Notice under Section 708(A) of the Corporations Act  18/10/2021 5:51PM
Application for quotation of securities - OCC  18/10/2021 5:48PM
Change of Director's Interest Notices  24/09/2021 9:53AM
Letter to Shareholders - Annual General Meeting  21/09/2021 6:26PM
Notice of Annual General Meeting/Proxy Form  21/09/2021 6:14PM
Notice under Section 708(A) of the Corporations Act  16/09/2021 6:35PM
Application for quotation of securities - OCC  16/09/2021 6:35PM
Proposed issue of securities - OCC  16/09/2021 6:28PM
Proposed issue of securities - OCC  16/09/2021 6:16PM
Positive Data for CelGro Collagen Rope in ACL Reconstruction  15/09/2021 9:29AM
OCC Secures Patents for Suture-Less Repair of Soft Tissue  07/09/2021 9:50AM
Proactive Investors Interview with Orthocells MD  02/09/2021 2:34PM
Ortho-ATI Shoulder Tendon Study Update Revised  31/08/2021 10:11AM
Ortho-ATI Shoulder Tendon Study Update  31/08/2021 9:15AM
Appendix 4E and Annual Report to Shareholders  27/08/2021 6:38PM
Appendix 4G  27/08/2021 6:33PM
Annual General Meeting  27/08/2021 6:30PM
CelGro Nerve Study Results Presented at AOA annual Meeting  23/08/2021 9:26AM

Similar Companies

Related Articles

Load More

About Company

The company is engaged into regenerative medicine sector for chronic degenerative diseases and injury under the health care sector. It was listed in 2014 on the ASX under Pharmaceuticals, Biotechnology & Life Sciences industry group and is in South Street, Murdoch, Australia.

Corporate Information

company address Building 191 Murdoch University, South Street, MURDOCH, WA, AUSTRALIA, 6150

company phone(08) 9360 2888

company websitehttp://www.orthocell.com.au

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 --
30/12/2013 -- 0.000 --

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-26 2022
Report (Prelim) 2022-08-26 2022
Report (Interim) 2022-02-25 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 1.018 M 719,523 945,657 619,179 529,818
Other Revenue 38,631 82,940 282,899 265,034 511,023
Total Revenue 1.057 M 802,463 1.229 M 884,213 1.041 M
Interest Income 199,242 116,385 10,815 18,469 35,747
Interest Expenses 0 0 0 0 0
Expenses -12.252 M -9.714 M -9.526 M -8.719 M -7.054 M
EBITDA -11.195 M -8.911 M -8.298 M -7.834 M -6.013 M
Depreciation and Amortization -435,652 -260,513 -218,721 -193,316 -147,752
Depreciation -174,952 -59,803 -65,444 -75,364 -70,458
Amortisation -260,700 -200,710 -153,277 -117,952 -77,294
EBIT -11.631 M -9.172 M -8.516 M -8.028 M -6.161 M
Pre Tax Profit -11.431 M -9.056 M -8.506 M -8.009 M -6.125 M
Tax Expense 2.394 M 2.905 M 2.528 M 2.252 M 1.948 M
Net Profit After Tax -9.037 M -6.151 M -5.977 M -5.757 M -4.177 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 125,152 0 0
Reported Net Profit After Abnormal Items -9.037 M -6.151 M -5.852 M -5.757 M -4.177 M
Ending Shares 190.584 M 184.699 M 153.367 M 110.178 M 101.479 M
Weighted Average Shares 186.853 M 171.003 M 118.37 M 105.727 M 96.959 M
EPS After Abnormal Items (cents) -4.84 -3.6 -4.94 -5.45 -4.31
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 17.072 M 20.805 M 11.528 M 3.229 M 5.285 M
Total Non Current Assets 2.258 M 2.365 M 2.07 M 2.001 M 1.874 M
Total Assets 19.33 M 23.171 M 13.598 M 5.23 M 7.159 M
Total Current Liabilities 1.934 M 1.861 M 2.873 M 2.433 M 1.88 M
Total Non Current Liabilities 522,399 406,473 0 425,148 566,844
Total Liabilities 2.456 M 2.267 M 2.873 M 2.858 M 2.446 M
Net Assets 16.874 M 20.903 M 10.724 M 2.372 M 4.712 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -4.633 M -5.257 M -4.18 M -4.644 M -3.555 M
Net Invested Cash -188,520 -55,198 -368,739 -373,560 -363,485
Net Financing Cash Flows 709,147 14.517 M 12.875 M 2.882 M 3.783 M
Beginning Cash 20.442 M 11.236 M 2.91 M 5.046 M 5.182 M
End Cash Position 16.329 M 20.442 M 11.236 M 2.91 M 5.046 M
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 16.329 M 20.442 M 11.236 M 2.91 M 5.046 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK